Pharmaids Pharmaceuticals P/B Ratio
Pharmaids Pharmaceuticals (PHARMAID) P/B ratio is 2.47 (Moderate), book value per share ₹13.71 vs Healthcare average P/B of -0.01 — High - Premium to book value, growth expectations or asset-light model. View PHARMAID 52-week high low for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PHARMAID P/B Ratio — Valuation Insights & Book Value Analysis
Pharmaids Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 2.47 (Moderate). For live price, earnings yield and the full fundamental profile, see PHARMAID stock price BSE.
- Current PB is 25.7% below historical average
- Trading at premium to sector average PB of -0.01
Pharmaids Pharmaceuticals P/B Ratio Historical Trend
PHARMAID annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review PHARMAID earnings multiple to evaluate earnings-based valuation against sector peers.
PHARMAID Historical P/B Ratio — Book Value Per Share & Year-End Price
Pharmaids Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.35 | ₹13.71 | ₹32.24 | ₹48 | Moderate |
| 2025 | 3.03 | ₹15.71 | ₹47.66 | ₹55 | High |
| 2024 | 3.47 | ₹20.29 | ₹70.48 | ₹71 | High |
| 2023 | 4.44 | ₹10.95 | ₹48.68 | ₹23 | High |
PHARMAID vs Healthcare Peers — P/B Ratio Comparison
Pharmaids Pharmaceuticals P/B 2.47 vs Healthcare average -0.01, median 0.62 — range -6.55–1.14.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.14 | ₹70 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.74 | ₹118 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.16 | ₹43 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |